Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tenax Therapeutics Inc (NASDAQ:TENX)

0.39
Delayed Data
As of Sep 22
 +0.0199 / +5.38%
Today’s Change
0.31
Today|||52-Week Range
2.65
-80.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$11.0M

Company Description

Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing and commercializing novel therapeutic products for the critical care market. The company intends to develop Levosimendan, a calcium sensitizer for intravenous use in hospitalized patients with acutely decompensated heart failure. Tenax Therapeutics was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Contact Information

Tenax Therapeutics, Inc.
ONE Copley Parkway
Morrisville North Carolina 27560
P:(919) 855-2100
Investor Relations:

Employees

Shareholders

Individual stakeholders5.10%
Mutual fund holders4.21%
Other institutional2.54%

Top Executives

Michael B. JebsenPresident, CEO, CFO & Treasurer
Doug RandallExecutive VP-Commercial & Business Operations
Nancy J. HecoxSecretary, EVP-Legal Affairs & General Counsel
Douglas HayExecutive Vice President-Regulatory Affairs